PTHS
Pelthos Therapeutics Inc.
NYSE MKT: PTHS · HEALTHCARE · BIOTECHNOLOGY
$25.09
+0.48% today
Updated 2026-04-29
Market cap
$83.79M
P/E ratio
—
P/S ratio
4.99x
EPS (TTM)
$-23.04
Dividend yield
—
52W range
$9 – $38
Volume
0.0M
Pelthos Therapeutics Inc. (PTHS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-257.90%
Operating margin
-127.80%
ROE
-239.60%
ROA
-29.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $199934.00 | $-660584.00 | 100.00% | -677.16% | -330.40% |
| 2021 | $0.00 | $-595387.00 | — | — | — |
| 2022 | $0.00 | $-2.46M | — | — | — |
| 2023 | $0.00 | $-7.38M | — | — | — |
| 2024 | $0.00 | $-7.96M | — | — | — |
| 2025 | $16.80M | $-43.32M | 62.65% | -193.09% | -257.93% |